CRSP CRISPR THERAPEUTICS AG
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 26 analyst firms say about CRISPR THERAPEUTICS AG: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
26 rated views · 27 analyst/firm records · 26 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8038
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8038
Recent analyst activity · last 90 days
Our tracked history has 14 reports on CRSP from 9 analyst firms in the last 90 days (26 firms in the past year).
Comparing each firm's latest target with its previous one: 1 lowered it and 6 left it unchanged.
No firm's latest available rating differs from its previous one.
Latest observed target change: Wells Fargo lowered its target from $75.00 (set 1 Jun 2026) to $70.00 on 4 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Jack K Allen | Hold | 1 Jun 2026 | 44.00 USD |
| Bank of America Securities | Geoff Meacham | Buy | 22 Jan 2026 | 89.00 USD |
| Bernstein | William Pickering | Hold | 13 May 2026 | 56.00 USD |
| Brookline Capital Markets | Leah R Cann | Buy | 4 Aug 2026 | 291.00 USD |
| Cantor Fitzgerald | Eric Schmidt | Hold | 23 Mar 2026 | — |
| Chardan Capital Markets | Geulah Livshits | Buy | 14 Feb 2026 | 76.00 USD |
| Citigroup | Yigal Nochomovitz | Buy | 3 Nov 2026 | 90.00 USD |
| Citizens JMP | Silvan C Tuerkcan | Buy | 6 Jul 2026 | 80.00 USD |
| Citizens JMP | Silvan Turkcan | Buy | 31 Aug 2026 | 80.00 USD |
| Evercore ISI | Jonathan Miller | Buy | 13 Feb 2026 | Conflicting reports · excluded |
| Goldman Sachs | Salveen Richter | Hold | 25 Jun 2026 | 55.00 USD |
| Guggenheim | Debjit Chattopadhyay | Hold | 8 Jul 2026 | — |
| H.C. Wainwright | Mitchell S. Kapoor | Buy | 9 Oct 2026 | 80.00 USD |
| Jefferies | Maury Raycroft | Buy | 4 Aug 2026 | 100.00 USD |
| Mizuho | Salim Syed | Buy | 30 Mar 2026 | 85.00 USD |
| Morgan Stanley | Maxwell Skor | Hold | 11 Jun 2026 | 60.00 USD |
| Needham | Gil Blum | Buy | 31 Aug 2026 | 82.00 USD |
| Piper Sandler | Edward A Tenthoff | Buy | 2 Nov 2026 | 110.00 USD |
| RBC Capital Markets | Luca Issi | Hold | 29 May 2026 | 50.00 USD |
| TD Cowen | Tyler Van Buren | Hold | 13 Feb 2026 | 45.00 USD |
| Truist | Unnamed analyst | Buy | 25 Mar 2026 | — |
| UBS | Joon Lee | Hold | 15 Oct 2026 | 52.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Wells Fargo | Yanan Zhu | Hold | 4 Nov 2026 | 70.00 USD |
| William Blair | Myles R Minter | Buy | 23 Sep 2026 | — |
| Wolfe Research | Andy G Chen | Hold | 27 Feb 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 12 Feb 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:39 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.